Eplerenone administration has beneficial effect on hepatic paraoxonase 1 activity in diabetic mice.
Noll
Christophe
C
Messaoudi
Smail
S
Milliez
Paul
P
Samuel
Jane-Lise
JL
Delcayre
Claude
C
Janel
Nathalie
N
D000818:Animals; D043303:Aryldialkylphosphatase / Q000378:metabolism*; D003921:Diabetes Mellitus, Experimental / Q000188:drug therapy* / Q000201:enzymology*; D000077545:Eplerenone; D051379:Mice; D013148:Spironolactone / Q000031:analogs & derivatives* / Q000627:therapeutic use
D013148:Spironolactone; D000077545:Eplerenone; D043303:Aryldialkylphosphatase